Blood System Drugs

download Blood System Drugs

of 27

Transcript of Blood System Drugs

  • 8/3/2019 Blood System Drugs

    1/27

    Transport Nutrients to and from

    tissue cells

  • 8/3/2019 Blood System Drugs

    2/27

    The arteries carry oxygenated blood (bloodthat has received oxygen from the lungs) fromthe heart to the rest of the body.

    The blood then travels through the veins backto the heart and lungs, where it receives moreoxygen.

  • 8/3/2019 Blood System Drugs

    3/27

  • 8/3/2019 Blood System Drugs

    4/27

    Cell full of hemoglobin

    Blood gets its bright red color whenhemoglobin picks up oxygen in thelungs.

    As the blood travels through the body,the hemoglobin releases oxygen to thetissues.

  • 8/3/2019 Blood System Drugs

    5/27

    These are colorless cells and possess a nucleus.

    They function in defending the body against

    pathogens.

    Lymphocytes agranulocytes - produceantibodies, the specific defence proteins.

    Made in bone marrow and lymphatic tissue.

  • 8/3/2019 Blood System Drugs

    6/27

    Responsible for clotting of the blood

    Responsible for repair of damaged tissue releasing the hormone platelet growthfactor.

  • 8/3/2019 Blood System Drugs

    7/27

  • 8/3/2019 Blood System Drugs

    8/27

    Iron deficiency anemia.

    Anemia due to chronic disease. Anemia due to kidney disease.

    Autoimmune hemolytic anemia.

  • 8/3/2019 Blood System Drugs

    9/27

  • 8/3/2019 Blood System Drugs

    10/27

    Neutropenia

    Human immunodeficiencyvirus (HIV)

    Leukemia

  • 8/3/2019 Blood System Drugs

    11/27

  • 8/3/2019 Blood System Drugs

    12/27

    Thrombocytopenia

    Hemophilia

  • 8/3/2019 Blood System Drugs

    13/27

    Thrombosis is the formationof a clot.

    A thrombus may form in any vessel,artery, or vein when blood flow isimpeded.

  • 8/3/2019 Blood System Drugs

    14/27

    Anticoagulants are used to prevent theformation and extension of a thrombus (bloodclot).

  • 8/3/2019 Blood System Drugs

    15/27

  • 8/3/2019 Blood System Drugs

    16/27

    GENERIC NAME TRADE NAME USES ADVERSEREACTIONS

    Anisindioneah-nis-in-dye-on

    Miradon Prophylaxis andtreatment of venous

    thrombosis and its

    extension; preventionand treatment ofatrial fibrillation with

    embolization,prophylaxis andtreatment ofpulmonary embolism

    Hemorrhage, nausea,

    alopecia, dermatitis,

    vomiting, anorexia,

    abdominal cramping,

    nausea,

    Warfarin sodium Coumadin, generic Venous thrombosis,atrial fibrillation with

    embolism, pulmonary

    embolism (PE),prophylaxis ofsystemic embolismafter acute MI

    Nausea, alopecia,

    hemorrhage, urticaria,

    dermatitis, vomiting,

    anorexia, abdominalcramping, priapism

  • 8/3/2019 Blood System Drugs

    17/27

    GENERIC NAME

    TRADE NAME

    USES

    ADVERSEREACTIONS

    heparin Generic Thrombosis/embolism, diagnosis and

    treatment of

    disseminated

    intravascular

    coagulation (DIC),

    prophylaxis of

    deep vein

    thrombosis (DVT),

    clotting prevention

    Hemorrhage,

    chills, fever,

    urticaria, local

    irritation,

    erythema, mild

    pain, hematoma or

    ulceration at the

    injection site (IM or

    SC), bruising

    10,00020,000

    units SC in divided

    doses q812h;

    500010,000 units

    q46h intermittent

    IV; 5000

    40,000

    units/d IV

    infusion; 5000

    unitsSC q2h before

    surgery and 5000

    units SC aftersurgery q812h

    heparin sodium

    lock flush solutionClearing

    intermittent

    infusion lines

    (heparin lock) to

    prevent clotformation at site

    None significant 10100 units/mLheparin solution

  • 8/3/2019 Blood System Drugs

    18/27

    GENERIC NAME TRADE NAME USES ADVERSEREACTIONS

    dalteparin sodium Fragmin Unstableangina/non Q-

    wave MI, DVT

    prophylaxis

    Hemorrhage,

    bruising,

    thrombocy-

    topenia, chills,

    fever, pain,erythema and

    irritation at site of

    injection

    Angina/MI: 120

    IU/kg, SC q12h

    with concurrent

    oral aspirin; DVT:

    2500 IU SC daily

    Danaparoid

    sodiumOrgaran Prophylaxis of

    DVT, after hip

    replacement

    surgery

    Hemorrhage,

    bruising, thrombo-

    cytopenia,

    hyperkalemia,

    hypersensitivity,

    fever, pain anderythema at

    injection site

    750 anti-Xa units

    BID SC

  • 8/3/2019 Blood System Drugs

    19/27

    GENERIC NAME TRADE NAME USES ADVERSEREACTIONS

    Enoxaparin sodiumLovenox DVT and prophylaxis,

    DVT and pulmonary

    embolism (PE)

    treatment, unstable

    angina/nonQ-wave

    MI

    Hemorrhage, bruising,

    thrombo-cytopenia,

    hyperkalemia,

    hypersensitivity, fever,

    pain and erythema at

    injection site

    DVT prophylaxis: 30

    mg q12h SC or 40 mg

    once daily SC; in

    abdominal surgery for

    patients at risk for

    thromboembolic

    complications: 40

    mg/d SC;DVT/PE treatment:1 mg/kg SC q12h;unstableangina, nonQ-wave

    MI:1 mg/kg SC

    q12hANTICOAGULA

    NTSTinzaparin sodium Innohep Treatment of acute,

    symptomatic DVTwith

    or without pulmonary

    emboli when given

    with warfarin sodium

    Hemorrhage, bruising,thrombo-cytopenia,

    hyperkalemia,

    hypersensitivity, fever,

    pain and erythema at

    injection site

    175 anti-Xa IU/kg/dSC once daily; 175

    IU/kg/d SC once daily

    until the patient has

    been successfully

    anticoagulated with

    warfarin

  • 8/3/2019 Blood System Drugs

    20/27

    GENERIC NAME TRADE NAME USES ADVERSEREACTIONS

    Phytonadione

    (vitamin K)Aqua-mephyton,

    Mephyton, genericPrevention and

    treatment of hypopro-

    thrombinemia

    associated with

    excessivedoses of oralanticoagulants

    Gastric upset,

    unusual taste,

    flushing, rash,

    urticaria, erythema,

    pain and/or swelling

    at injection site

    may repeat PO in

    1248 h PO, IM,

    2.5

    10 mg, or in 6

    8

    h after parenteral

    dose

    Protamine sulfateAcute management of

    heparin overdosage

    (neutralizes heparin)

    Dyspnea,

    bradycardia,

    hypotension,hypertension,

    bleeding,

    hypersensitivity

    reactions

    Dose is determined

    by amount of heparin

    in body and the timethat has elapsed

    since the heparin was

    given; the longerthe interval, the

    smaller thedose required.Adult and pediatric:

    1mg IVneutralizes 90 USP

    units ofheparin derived from

    lungtissue or 115 USP

    units ofheparin derived fromintestinal mucosa

  • 8/3/2019 Blood System Drugs

    21/27

    Thrombolytics are a group of drugsused to dissolve certain types of

    blood clots and reopen blood vesselsafter they have been occluded.

  • 8/3/2019 Blood System Drugs

    22/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    alteplase, Activase Acute myocardial Bleeding (GU, gingival, AMI: total dose of 100 mg

    recombinant infarction (AMI), retroperitoneal), and IV given as 60 mg

    acute ischemic epistaxis, ecchymosis 1st h, 20 mg 2nd h

    stroke, pulmonary and 20 mg over 3rd h

    embolism (PE) for patients < 65 kg,

    decrease dose to

    1.25 mg/kg

    reteplase, Retavase AMI Bleeding (GI, GU, or at injection 10 plus 10 U double bolus

    recombinant site), intracranial hemorrhage, IV over 2 min each with the

    anemia 2nd bolus given 30 min

    after the 1st

    streptokinase Streptase AMI, DVT, PE, Minor bleeding (superficial and Lysis of coronary arteryembolism surface) and major bleeding thrombosis, 20,000

    (internal and severe) IU directly into vein;

    PE, DVT, embolism:

    250,000 IU IV

    over 30 min followed by

    100,000 IU for 2472 h

  • 8/3/2019 Blood System Drugs

    23/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    tenecteplase TNKase AMI Bleeding (GI, GU, or at injection Dosage based on weight,site), intracranial hemorrhage, not to exceed 50 mg IV

    anemia

    urokinase Abbokinase PE, lysis of coronary Minor bleeding (superficial and PE: 4400 IU/kg IV

    artery thrombi, IV surface) and major bleeding over 10 min, followed by

    catheter clearance (internal and severe) 4400 IU/kg/hr for 12 h;

    lysis of thrombi: 6000IU/min IV for 2 h; IV

    catheter clearance: see

    packaged instructions

  • 8/3/2019 Blood System Drugs

    24/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    darbepoetin alfa Aranesp Anemia associated Hypertension, hypotension, 0.45 mcg/kgwith chronic headache, diarrhea, vomiting, IV, SC weeklyrenal failure nausea, myalgia, infection,

    cardiac arrhythmias, cardiacarrest

    epoetin alfa Epogen, Anemia associated Hypertension, headache, Individualized dosage CRF

    (Erythropoietin; procrit with chronic renal tachycardia, nausea, vomiting, 50100 U/kg (3 times(EPO) failure, anemia related skin rashes, fever, skin reaction weekly IV or SC),

    to zidovudine therapy at injection site maintenance based onin HIV-infected patients, HCT, generally 25 U/kg

    anemia in cancer 3 times weekly;patients receiving zidovudine-treated HIV

    chemotherapy, infected patients: 100anemia in patients who U/kg 3 times weekly;

    undergo elective cancer: 150 U/kg 3nonvascular surgery times weekly;surgery: 300 U/kg/d

    SC x 10 d beforesurgery, on day ofsurgery and 4 days

    after surgery

  • 8/3/2019 Blood System Drugs

    25/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    ferrous fumarate Feostat, Prevention and GI irritation, nausea, vomiting, Daily requirements:

    (33% elemental generic treatment of iron constipation, diarrhea, males, 10 mg/d PO;iron) deficiency anemia allergic reactions females, 18 mg/d PO;

    during pregnancy andlactation, 3060 mg/dPO; replacement indeficiency states,90300 mg/d(6 mg/kg/d) POfor 610 months

    ferrous gluconate Fergon, Prevention and GI irritation, nausea, vomiting, Daily requirements:(11.6% elemental generic treatment of iron constipation, diarrhea, males, 10 mg/d PO;iron) deficiency anemia allergic reactions females, 18 mg/d PO;

    during pregnancy andlactation, 3060 mg/dPO; replacement indeficiency states,

    90300 mg/d(6 mg/kg/d) POfor 610 months

  • 8/3/2019 Blood System Drugs

    26/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    ferrous sulfate Feosol, Prevention and GI irritation, nausea, vomiting, Daily requirements:(20% elemental Fer-In-Sol, treatment of iron onstipation, diarrhea, males, 10 mg/d PO;iron) generic eficiency anemia allergic reactions females, 18 mg/d PO;

    during pregnancy andlactation, 3060 mg/dPO; replacement indeficiency states,90300 mg/d(6 mg/kg/d) POfor 610 months

    folic acid Folvite, Megaloblastic anemia Allergic sensitization Up to 1 mg/dgeneric due to deficiency of PO, IM, IV, SCfolic acid

    iron dextran DexFerrum, Iron deficiency Anaphylactoid reactions, Dosage based on bodyInFeD, anemia soreness and inflammation weight and gramsGeneric at injection site, chest pain, percent (g/dL) of

    arthralgia, backache, hemoglobin IV, IMconvulsions, pruritus,

    abdominal pain, nausea,vomiting, dyspnea

    iron sucrose Venofer Iron deficiency Hypotension, cramps, leg 100 mg elemental ironanemia cramps, nausea, headache, slow IV or during

    vomiting, diarrhea, dizziness dialysis session

  • 8/3/2019 Blood System Drugs

    27/27

    GENERIC NAME TRADE NAME* USES ADVERSE REACTIONS DOSAGE RANGES

    Ieucovorin Wellcovorin, Treatment of Allergic sensitization, Megaloblastic anemia:

    Calcium generic megaloblastic urticaria, anaphylaxis 1 mg/d IM rescue after

    anemia leucovorin methotrexate therapy:

    rescue after high-dose 1215 g/m2 PO

    methotrexate therapy or parentearally then

    in osteosarcoma 10 mg/m2 q6h for 72 h;

    check serum creatinine

    after 24 h; if 50% greater

    than the pretreatment

    level, increase Ieucovorin

    dose to 100 mg/m2 until

    serum methotrexate level

    is 15 _ 10-8 M

    sodium ferric Ferrlecit Iron deficiency Flushing, hypotension, 125 mg of elemental iron

    gluconate syncope, tachycardia, IV over at least

    complex dizziness, pruritus, dyspnea, 10 min

    conjunctivitis, hyperkalemia

    vitamin B12 generic B12 deficiencies as seen Mild diarrhea, itching, Schillings test:

    (cyanocobalamin) in pernicious anemia, edema, anaphylaxis 1001000 mcg/d x

    GI pathology; also 2 wk, then 100-1000

    used when mcg IM q mo

    requirements for the

    vitamin are increased;

    Schillings test